Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: Possible associations with inflammation

Diabetes Care

Volumn 33, Issue 9, 2010, Pages 1990-1996

  Wannamethee, S Goya ^a   Shaper, A Gerald ^a   Rumley, Ann ^b   Sattar, Naveed ^b   Whincup, Peter H ^c   Thomas, Mary C ^a   Lowe, Gordon D ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INTERLEUKIN 6; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; DISEASE ASSOCIATION; FATALITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HUMAN; IMMOBILIZATION; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77958151512     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0324     Document Type: Article

References (25)

1. Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD, Heiss G. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003;158:1171-1181 (Pubitemid 37548787)
2. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952-1959
3. van den Borst B, Gosker HR, Zeegers MP, Schols AMWL. Pulmonary function in diabetes: a meta-analysis. Chest. 26 March 2010 [Epub ahead of print]
4. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Cox CE, Selvin E, Brancati FL. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008;31:741-746
5. Engström G, Janzon L. Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med 2002;19:167-170 (Pubitemid 34225233)
6. Ford ES, Mannino DM, National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study. Diabetes Care 2004;27:2966-2970
7. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005;28:1472-1479 (Pubitemid 40756715)
8. Engström G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003;253:574-581 (Pubitemid 36543297)
9. Engström G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgärde F. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002;106:2555-2560 (Pubitemid 35340691)
10. Engström G, Hedblad B, Janzon L. Reduced lung function predicts increased fatality in future cardiac events: a population-based study. J Intern Med 2006;260:560-567 (Pubitemid 44772376)
11. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004:59:574-580 (Pubitemid 38901515)
12. Engström G, Hedblad B, Stavenow L, Tydén P, Lind P, Janzon L, Lindgärde F. Fatality of future coronary events is related to inflammation-sensitive plasma proteins: a population-based prospective cohort study. Circulation 2004;110:27-31 (Pubitemid 38880130)
13. Sattar N, Murray HM, Welsh P, Blauw GJ, Buckley BM, Cobbe S, de Craen AJ, Lowe GD, Jukema JW, Macfarlane PW, Murphy MB, Stott DJ, Westendorp RG, Shepherd J, Ford I, Packard CJ. Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Study Group. Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Med. 23 June 2009 [Epub ahead of print]
14. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, Thomson AG. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ 1981;283:179-186 (Pubitemid 11071686)
15. Wannamethee G, Whincup PH, Shaper AG, Walker M, MacFarlane PW. Factors determining case fatality in myocardial infarction "who dies in a heart attack." Br Heart J 1995;74:324-331
16. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepatic enzymes, the metabolic syndrome and the risk of type 2 diabetes in older men. Diabetes Care 2005;28:2913-2918 (Pubitemid 43942924)
17. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: prospective study and update meta-analyses. BMJ 2000;321:199-204 (Pubitemid 30459555)
18. Cole TJ. Linear and proportional regression models in the prediction of ventilatory function: with discussion. J R Stat Soc Ser A 1975;138:297-338
19. Cook DG, Shaper AG. Breathlessness, lung function and the risk of heart attack. Eur Heart J 1988;9:1215-1222 (Pubitemid 19010172)
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;6(Suppl. 16):5-40
21. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005;162:975-982 (Pubitemid 41619468)
22. Marcus EB, Curb JD, MacLean CJ, Reed DM, Yano K. Pulmonary function as a predictor of coronary heart disease. Am J Epidemiol 1989;129:97-104 (Pubitemid 19030702)
23. Fimognari FL, Pasqualetti P, Moro L, Franco A, Piccirillo G, Pastorelli R, Rossini PM, Incalzi RA. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J Gerontol A Biol Sci Med Sci 2007;62:760-765 (Pubitemid 350143608)
24. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004;47:195-203 (Pubitemid 38315355)
25. Pearte CA, Furberg CD, O'Meara ES, Psaty BM, Kuller L, Powe NR, Manolio T. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Circulation 2006;113:2177-2185